Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke Risk

This article originally appeared here.
Share this content:
Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke Risk
Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke Risk

FRIDAY, Aug. 18, 2017 (HealthDay News) -- Radioiodine (I-131) therapy for thyroid cancer is not associated with increased risk of stroke, according to a study published online Aug. 16 in Head & Neck.

Chun-Yi Lin, M.D., from Show Chwan Memorial Hospital in Changhua, Taiwan, and colleagues examined the correlation between I-131 therapy for thyroid cancer and the risk of stroke among 10,104 patients aged 20 years or older newly diagnosed with thyroid cancer during 2000 to 2010. Patients were classified into two cohorts according to receipt of I-131 therapy through 1:1 propensity score matching.

The researchers found that the risk of ischemic stroke (adjusted hazard ratio, 1.05; 95 percent confidence interval, 0.82 to 1.34) or hemorrhagic stroke (adjusted hazard ratio, 1.06; 95 percent confidence interval, 0.58 to 1.93) was not significantly higher for the I-131 therapy group versus the non-I-131 therapy group, after adjustment for age, sex, and comorbidities.

"The I-131 treatment for thyroid cancer did not increase the risk of stroke during up to 10 years of follow-up," the authors write. "However, a longer follow-up period is needed to assess late adverse effects occurring after 10 years."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Amount of Opioids Prescribed After Hospital Discharge Varies

Amount of Opioids Prescribed After Hospital Discharge Varies

45.6 percent of patients using no opioids 24 hours predischarge were prescribed opioids at discharge

Observation Care Cost Saving in Commercially-Insured Patients

Observation Care Cost Saving in Commercially-Insured Patients

Total, out-of-pocket spending considerably lower for observation care; both increased from '09 to '13

Disrupted Sleep Linked to Increased Amyloid- Production

Disrupted Sleep Linked to Increased Amyloid-β Production

Sleep deprivation tied to increased overnight amyloid-β-38, -40, -42 levels by 25 to 30 percent

is free, fast, and customized just for you!

Already a member?

Sign In Now »